Abstract
Background: An increase in inflammatory response and an imbalance between T-helper (Th) 1 and
2 functions have been implicated in major depression. The aims of the present study
were to 1) study the relationship between pro- and anti-inflammatory cytokines and
between Th1 and Th2 produced cytokines in depressed patients and 2) evaluate and compare
the effect of treatments with electroacupuncture (EA) and fluoxetine on these cytokines.
Methods: 95 outpatients with major depressive disorder were treated for 6 weeks with EA, fluoxetine
or placebo. Hamilton Depression Rating Scale (HDRS) and Clinical Global Impression
(CGI) were used to assess severity and therapeutic effects. 30 volunteers served as
controls. Serum cytokine concentrations were measured by ELISA.
Results: Increased proinflammatory cytokine interleukin (IL)-1β and decreased anti-inflammatory
cytokine IL-10 were found in the depressed patients. By contract, Th1 produced proinflammatory
cytokines, tumor necrosis factor (TNF)-α and interferon (IFN)-γ were decreased, and
Th2 produced cytokine IL-4 was significantly increased in depressed patients. The
ratio of IFN/IL-4 was also increased. Both acupuncture and fluoxetine treatments,
but not the placebo, reduced IL-1β concentrations in responders. However, only acupuncture
attenuated TNF-α concentration and INF-γ/IL-4 ratio towards the control level.
Discussion: These results suggest that an imbalance between the pro- and anti-inflammatory cytokines
(IL-1 and IL-10), and between Th1 and Th2 cytokines (INF-γ or TNF-α and IL-4) occurred
in untreated depressed patients. Both EA and fluoxetine had an anti-inflammatory effect
by reducing IL-1β. EA treatment also restored the balance between Th1 and Th2 systems
by increasing TNF-α and decreasing IL-4.
References
1
Licinio J, Wong ML.
The role of inflammatory mediators in the biology of major depression: central nervous
system cytokines modulate the biological substrate of depressive symptoms, regulate
stress-responsive systems, and contribute to neurotoxicity and neuroprotection.
Mol Psychiatry.
1999;
4
317-427
2
Maes M, Smith R, Scharpe S.
The monocyte-T-lymphocyte hypothesis of major depression.
Psychoneuroendocrinology.
1995;
20
111-116
3
Bry K, Teramo K, Lappalainen U. et al .
Interleukin-1 receptor antagonist in the fetomaternal compartment.
Acta Paediatr.
1995;
84
233-236
4
Song C, Lin A, Bonaccorso S. et al .
The inflammatory response system and the availability of plasma tryptophan in patients
with primary sleep disorders and major depression.
J Affect Disord.
1998;
49
211-219
5
Cassidy EM, Manning D, Byrne S. et al .
Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6.
Psychopharmacol.
2002;
16
230-234
6 Hirschfeld RMA, Goodwin FK. Mood disorders.
In Textbook of Psychiatry (eds: Talbott JA, Hales RE, Yudofsky SC) . Washington: American Psychiatric Press 1988
7
Capuron L, Ravaud A, Dantzer R.
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon
alfa-2b therapy.
J Clin Oncol.
2000;
18
2143-2151
8
Meyers CA.
Mood and cognitive disorders in cancer patients receiving cytokine therapy.
Adv Exp Med Biol.
1999;
461
75-81
9
Maes M, Bosmans E, Suy E. et al .
Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1
beta and soluble interleukin-2 receptor production.
Acta Psychiatr Scand.
1991;
84
379-386
10
Fearon DT, Locksley RM.
The instructive role of innate immunity in the acquired immune response.
Science.
1996;
272
50-53
11
Maes M, Bosmans E, Jongh R De. et al .
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression
and treatment resistant depression.
Cytokine.
1997;
9
853-858
12
Nassberger L, Traskman-Bendz L.
Increased soluble interleukin-2 receptor concentrations in suicide attempters.
Acta Psychiatr Scand.
1993;
88
48-52
13
Connor TJ, Song C, Leonard BE. et al .
An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis
factor-alpha administration on some behavioural, neurochemical, endocrine and immune
parameters in the rat.
Neuroscience.
1998;
84
923-933
14
Song C, Leonard BE, Horrobin DF.
Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced
changes in behavior, corticosterone and immune response in rats.
Stress.
2004;
7
43-54
15
Hamilton A.
A rating scale for depression.
J Neural Neurosurge Psychiatry.
1960;
23
56-62
16
Li QQ, Bever CT.
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending
on de novo transcription.
Neurochem Res.
2001;
26
125-133
17
National Institute of Mental Health
.CGI: Clinical Global Impression.
In: Manual 40 ECDEU Assessment Battery, Volume 2 revised edition . Guy, W.: Bonatorr (Editors), NIMH, Chevy Chase MD 1970: 21-26
18
Salem ML.
Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations
by differential regulation of TH1/TH2 cytokine production.
Curr Drug Targets Inflamm Allergy.
2004;
3
97-104
19
Schwarz MJ, Chiang S, Muller N. et al .
T-helper-1 and T-helper-2 responses in psychiatric disorders.
Brain Behav Immun.
2001;
15
340-370
20
Pavon L, Sandoval-Lopez G, Eugenia Hernandez M. et al .
Th2 cytokine response in Major Depressive Disorder patients before treatment.
J Neuroimmunol.
2006;
172
156-165
21
Myint AM, Leonard BE, Steinbusch HW. et al .
Th1, Th2, and Th3 cytokine alterations in major depression.
J Affect Disord.
2005;
88
167-173
22
Ravindran AV, Griffiths J, Merali Z. et al .
Lymphocyte subsets associated with major depression and dysthymia: modification by
antidepressant treatment.
Psychosom Med.
1995;
57
555-563
23
Sluzewska A, Rybakowski JK, Laciak M. et al .
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine.
Ann N Y Acad Sci.
1995;
762
474-476
24
Maes M, Song C, Lin AH. et al .
Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma
and stimulation of interleukin-10 secretion.
Neuropsychopharmacology.
1999;
20
370-379
25
Xia Z, DePierre JW, Nassberger L.
Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood
monocytes and IL-2 and interferon-gamma in T cells.
Immunopharmacology.
1996;
34
27-37
26
Chang FC, Tsai HY, Yu MC. et al .
The central serotonergic system mediates the analgesic effect of electroacupuncture
on ZUSANLI (ST36) acupoints.
J Biomed Sci.
2004;
11
179-185
27
Ma QP, Zhou Y, Yu YX. et al .
Electroacupuncture accelerated the expression of c-fos protooncogene in serotonergic
neurons of nucleus raphe dorsalis.
Int J Neurosci.
1992;
67
111-117
28
Song C, Chen RY.
The effect of acupuncture on the uptake of [3H]-5-HT in the raphe nuclei of midbrain
of adult and aging rats.
J Tsinghua University (China).
1992;
31
78-83
29
Yano T, Kato B, Fukuda F. et al .
Alterations in the function of cerebral dopaminergic and serotonergic systems following
electroacupuncture and moxibustion applications: possible correlates with their antistress
and psychosomatic actions.
Neurochem Res.
2004;
29
283-293
30
Mendlovic S, Mozes E, Eilat E. et al .
Immune activation in non-treated suicidal major depression.
Immunol Lett.
1999;
67
105-108
31
Brambilla F, Maggioni M.
Blood levels of cytokines in elderly patients with major depressive disorder.
Acta Psychiatr Scand.
1998;
97
309-313
32
Natelson BH, Denny T, Zhou XD. et al .
Is depression associated with immune activation?.
J Affect Disord.
1999;
53
179-184
33
Owen BM, Eccleston D, Ferrier IN. et al .
Raised levels of plasma interleukin-1beta in major and postviral depression.
Acta Psychiatr Scand.
2001;
103
226-228
34
Schlatter J, Ortuno F, Cervera-Enguix S.
Monocytic parameters in patients with dysthymia versus major depression.
J Affect Disord.
2004;
78
243-247
35
Hestad KA, Tonseth S, Stoen CD. et al .
Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization
during electroconvulsive therapy.
J ECT.
2003;
19
183-188
36
Tuglu C, Kara SH, Caliyurt O. et al .
Increased serum tumor necrosis factor-alpha levels and treatment response in major
depressive disorder.
Psychopharmacology (Berl).
2003;
170
429-433
37
Haack M, Hinze-Selch D, Fenzel T. et al .
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients
upon hospital admission: effects of confounding factors and diagnosis.
J Psychiatr Res.
1999;
33
407-418
38
Kraus T, Haack M, Schuld A. et al .
Body weight, the tumor necrosis factor system, and leptin production during treatment
with mirtazapine or venlafaxine.
Pharmacopsychiatry.
2002;
35
220-225
39
Song C, Horrobin DF, Leonard BE.
The comparison of changes in behavior, neurochemistry, endocrine, and immune functions
after different routes, doses and durations of administrations of IL-1beta in rats.
Pharmacopsychiatry..
2006;
39
88-99
40
Asai K, Hiki N, Mimura Y. et al .
Gender differences in cytokine secretion by human peripheral blood mononuclear cells:
role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic
model.
Shock.
2001;
16
340-343
41
Rook GA, Zumla A.
Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2
profile?.
Lancet.
1997;
349
1831-1833
42
Rothermundt M, Arolt V, Fenker J. et al .
Different immune patterns in melancholic and non-melancholic major depression.
Eur Arch Psychiatry Clin Neurosci.
2001;
251
90-97
43
Kubera M, Lin AH, Kenis G. et al .
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10
production ratio.
J Clin Psychopharmacol.
2001;
21
199-206
44
Merali Z, Brennan K, Brau P. et al .
Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant
and gender effects on responding for “free chow” and “earned” sucrose intake.
Psychopharmacology (Berl).
2003;
165
413-418
45
Yaron I, Shirazi I, Judovich R. et al .
Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic
acid production in human synovial cells and synovial tissue cultures.
Arthritis Rheum.
1999;
4
2561-2568
46
Yirmiya R, Pollak Y, Barak O. et al .
Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide
(LPS) in rodents.
Neuropsychopharmacology.
2001;
24
531-544
47
Fang JQ, Aoki E, Yu Y. et al .
Inhibitory effect of electroacupuncture on murine collagen arthritis and its possible
mechanisms.
In Vivo.
1999;
13
311-318
48
Jeong HJ, Hong SH, Nam YC. et al .
The effect of acupuncture on proinflammatory cytokine production in patients with
chronic headache: a preliminary report.
Am J Chin Med.
2003;
31
945-954
49
Park MB, Ko E, Ahn C. et al .
Suppression of IgE production and modulation of Th1/Th2 cell response by electroacupuncture
in DNP-KLH immunized mice.
J Neuroimmunol.
2004;
151
40-44
50
Tian L, Huang YX, Tian M. et al .
Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative
colitis.
World J Gastroenterol.
2003;
9
1028-1033
51
Xu ZF, Wu GC, Cao XD.
Effect of electroacupuncture on the expression of interlukin-1beta mRNA after transient
focal cerebral ischemia.
Acupunct Electrother Res.
2002;
27
29-35
52
Schuld A, Schmid DA, Haack M. et al .
Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated
with baseline cytokine levels, but not with cytokine responses to hydrocortisone.
J Psychiatr Res.
2003;
37
463-470
53
Smith RS.
The macrophage theory of depression.
Med Hypoth.
1991;
35
298-306
54
Han JS, Chen XH, Sun SL. et al .
Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity
in human lumbar CSF.
Pain.
1991;
47
295-298
55
Le Bars D, Dickerson AH, Besson JM.
Diffuse noxious inhibitory controls: effects on dorsal horn convergent neurons in
the rat.
Pain.
1979;
6
305-327
56
Nickel T, Sonntag A, Backmund M. et al .
Depression during therapy with interferon alpha–how long should an antidepressant
treatment last?.
Pharmacopsychiatry.
2005;
38
102-104
57
Song Y, Zhou D, Fan J. et al .
Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins
in platelet membrane in patients with major depressive disorder.
J Affect Disord.
2007;
98
253-257
Correspondence
C. SongMD, PhD
Neuroimmunology Research Lab
Department of Biomedical Science, AVC
University of Prince Edward Island
550 University Ave.
Charlottetown
P.E. Canada C1A 4P3
Telefon: 902/566/79 77
Fax: 902/566/74 68
eMail: cai.song@nrc.gc.ca